IL6 and central nervous system cancer: Using mouse patient-derived xenograft (PDX) models, it was shown that IL6, a universal SASP component as well as a cytokine expressed by immune cells, promotes the growth of patient glioma stem cells (GSCs) and contributes to glioma malignancy19.